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Summary. A 47 kDa neisserial outer-membrane antigenic protein (P47) was puri-
fied to homogeneity and used to prepare polyclonal anti-P47 antisera. Protein P47
was identified by MALDI-TOF fingerprinting analysis as the hypothetical lipopro-
tein NMB0035. Two-dimensional diagonal SDS-PAGE results suggested that, con-
trary to previous findings, P47 is not strongly associated with other proteins in mem-
brane complexes. Western blotting with the polyclonal monospecific serum showed
that linear P47 epitopes were expressed in similar amounts in the 27 Neisseria
meningitidis strains tested and, to a lesser extent, in commensal Neisseria, particu-
larly N. lactamica. However, dot-blotting assays with the same serum demonstrat-
ed binding variability between meningococcal strains, indicating differences in sur-
face accessibility or steric hindrance by other surface structures. Specific anti-P47
antibodies were bactericidal against the homologous strain but had variable activ-
ity against heterologous strains, consistent with the results from dot-blotting exper-
iments. An in-depth study of P47 is necessary to evaluate its potential as a candi-
date for new vaccine designs. [Int Microbiol 2006; 9(4):273-280]
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Introduction
Neisseria meningitidis is a gram-negative human parasite
whose outer membrane is surrounded by a polysaccharidic
capsule that is essential for its pathogenicity and which pro-
tects meningococcal cells. Capsular polysaccharide and pro-
teins located in the outer membrane are the main surface anti-
gens of this microorganism. However, environmental and
host factors cause a high variability in the antigenicity of
these structures, producing a great number of antigenic vari-
ants [14,27,28]. In addition to their variable capsular types,
meningococci carry out capsular switching, which represents
an important mechanism for immune evasion and limits the
effectiveness of existing vaccines [33,34].
Meningococcal meningitis and sepsis are severe process-
es, with mortality rates of about 10% but as high as 50% in
the absence of appropriate diagnoses and treatment.
Polysaccharidic vaccines developed in the 1960s confer
immunity against serogroups A, C, Y, and W135 in adults. In
infants and children, good control over disease produced by
serogroup C was recently obtained with vaccines based on
capsular polysaccharide chemically conjugated to carrier
proteins [2]. Serogroup A is the main cause of epidemics in
underdeveloped countries, and conjugated vaccines (similar
to that against serogroup C) are expected to effectively pre-
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vent disease caused by this serogroup. Nevertheless, this con-
jugation approach is not feasible for infection with serogroup
B meningococci, which has very high mortality rates in
developed countries [13]. Thus, research carried out over the
last few years has focused on the development of vaccines
based on outer-membrane proteins (OMPs), with the goal of
obtaining effective protection against disease produced by
serogroup B infection. While some attempts have involved
multiple antigenic variants [17], clinical assays have shown
that vaccines based on outer-membrane vesicles (OMVs)
elicit bactericidal antibodies and protection. However, they
are only effective against homologous strains because the
response is mainly directed against PorB and PorA (the
serotype and serosubtype antigens), which present high anti-
genic variability. Although these vaccines confer low immu-
nogenicity in children and generate only short-term respon-
ses, they may nonetheless be useful for the control of specific
outbreaks of serogroup B and in hyperendemic areas where
the number of antigenic variants is limited [21,26]. While
several other OMPs produce more effective vaccines
[6,7,23], a good candidate has not been found to date. The
OMP NadA induces bactericidal activity, but the gene coding
for this protein is present in only 50% of the strains [6]. Other
OMPs, such as PorB3 or NspA, are present in all strains but
their expression or surface accessibility differs between
strains [19,20].
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Table 1. Characteristics of the Neisseria strains used in this study
Strain1 Serogroup and serotype2 Origin Clonal complex
N. meningitidis
B16B6r
GLDi
NMBi
M7nc
Nm9i
Nm16i
Nm17i
Nm20i
Nm21i
Nm22i
Nm30i
Nm39i
Nm40i
Nm59i
Nm60i
Nm62i
Nm63i
Nm68i
Nm70i
NmP0c
NmP2c
NmP3c
NmP5c
NmP7c
NmP17c
NmP18c
NmP19c
N. lactamica
NlP3c
NlP5c
NlP6c
NlP9c
N. sicca
NsP4c
N. perflava
NpfP0c
B:2a:P1.5,2
C:2a:P1.5
B:2b:P1.2,5
B:2b:P1.2,5
C:2b:P1.2,5
B:4:P1.15
C:2b:P1.2,5
C:2b:P1.2,5
C:2b:P1.2,5
B:15:P1.16
C:2b:P1.2,5
B:2b:P1.2,5
B:2b:P1.2,5
C:NT:P1.3
B:4:P1.15
HA:2a:P1.5
B:12:P1.19,15
B:15:P1.19,15
B:4:P1.1
W135:NT:P1.3,6
B:4:P1.3
B:2a:P2,5
B:NT:P1.3,6
B:4:P1.3,6
W135:NT:P1.3
W135:NT:P1.3
C:15:NT
NA
NA
NA
NA
NA
NA
Cerebrospinal fluid
Cerebrospinal fluid
Cerebrospinal fluid
Cerebrospinal fluid
Cerebrospinal fluid
Cerebrospinal fluid
Blood
Cerebrospinal fluid
Blood
Cerebrospinal fluid
Cerebrospinal fluid
Blood
Blood
Cerebrospinal fluid
Blood
Cerebrospinal fluid
Cerebrospinal fluid
Blood
Cerebrospinal fluid
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
Oropharynx
ST8 complex, cluster A4
ST11complex, ET37 
ST11 complex, ET37
ST8 complex, cluster A4
ST8 complex, cluster A4
ST8 complex, cluster A4
ST32 complex, ET5
ST8 complex, cluster A4
ST8 complex, cluster A4
ST8 complex, cluster A4
ST32 complex, ET5
ST8 complex, cluster A4
ST8 complex, cluster A4
ST22 complex
ST32 complex, ET5
ST11 complex, ET37
ST32 complex, ET5
ST32 complex, ET5
ST32 complex, ET5
ST22 complex
ST22 complex
ST22 complex
ST198 complex
ST254 complex
ST11complex, ET37
ST174 **
ST32 complex, ET5
1NT, nontypeable; HA, highly agglutinable; NA, not applicable.
2Based on six genes matched. The only difference is a change in the adk gene from allele 5 (ST174 complex) to allele 16.  
ST-1251 is recorded in the MLST database with no clonal assignment.
rReference strain; iinvasive strain, ncnon-capsulated mutant of NMB, ccarrier strain
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The most important challenge in producing an effective
meningococcal vaccine based on OMPs is to find an antigen
or a group of antigens common to all strains and able to
induce long-term protective immune responses both in adults
and children. Previous studies in our laboratory demonstrat-
ed an immunological response in convalescent patients
against an antigenic neisserial OMP (P47) inducible by iron
restriction, and its antigenic cross-reactivity in a limited
number of neisserial strains [35]. The aim of the present work
was to purify and characterize P47 as well as to evaluate its
antigenic conservation and ability to elicit bactericidal
responses.
Materials and methods
Bacterial strains and culture conditions. The characteristics of
all strains used are listed in Table 1. N. meningitidis strains GLD and B16B6
were kindly provided by P. Borriello (Queen’s Medical Center, University
Hospital, Nottingham, UK); strain NMB, by D. Granoff (Children’s Hospi-
tal, Oakland Research Institute, Oakland, CA, USA); and strain M7 (a cap-
sule-deficient mutant of NMB), by M. Pizza (Istituto di Ricerca Immunobio-
logica di Siena, Siena, Italy). All other strains were from our laboratory.
Strains were maintained and cultured under iron-restricted conditions as des-
cribed previously [22].
Multilocus sequence typing. Multilocus sequence typing (MLST)
of each strain was done at the Instituto Carlos III (Madrid, Spain) by deter-
mination of the allelic profiles obtained from a 450-bp internal region in the
abcZ, adk, aroE, fum, gdh, pdhC, and pgm genes (Table 1). Assignation to
clonal complexes was done by comparing the profiles with those in the
meningococcal MLST database [http://pubmlst.org/neisseria/].
Extraction and purification of the P47 protein. OMPs were
extracted from strain N. meningitidis Nm30 using Triton X-114. Cells from
iron-restricted cultures were recovered, washed with 20 mM Tris-HCl, 500
mM NaCl, pH 7.5 (TSB), and suspended (0.1 g/ml) in chilled (4ºC) TSB con-
taining 0.02% (w/v) sodium azide and 4% (v/v) Triton X-114. The suspension
was incubated overnight at this temperature in a water bath with 200 rpm con-
stant shaking and then centrifuged at 10,000 ´g at 4ºC for 30 min to remove
cellular debris. The supernatant was incubated at 37ºC for 3 h to provoke
phase separation, and the detergent and aqueous phases were separately
recovered (discarding the interface). Proteins present in both phases were
identified by SDS-PAGE and Western blotting using an antiserum from mice
immunized with homologous OMVs. P47 was purified by elution after sepa-
ration on 4–15% gradient SDS-polyacrylamide gels, essentially as described
by Hager et al. [11]. Gel debris was discarded and the proteins were precipi-
tated with trichloroacetic acid [3]. Protein purity was checked by SDS-PAGE,
Western blotting with anti-OMV mouse sera, and MALDI-TOF peptide-map
fingerprinting analysis of bands cut from silver-stained gels.
SDS-PAGE and Western blotting. SDS-PAGE was carried out
according to standard protocols, using 12% polyacrylamide gels and the dis-
continuous buffer system described by Laemli [15]. For the analysis, bacte-
rial cells were fixed by adding 1% (v/v) formaldehyde to the culture just
after growth, followed by incubation at room temperature for 30 min with
100 rpm constant shaking. The cells were then washed twice with phos-
phate-buffered saline (PBS; 0.1 M sodium phosphate buffer, pH 7.2, con-
taining 0.1 M NaCl), resuspended at 109 cells per ml in PBS containing 0.05
mM phenylmethylsulfonyl fluoride (PMSF), and maintained at 4ºC until
needed. For some experiments, the cells were permeabilized with 70%
ethanol [19] and/or treated with chloroform vapor [24] prior to fixation.
Samples containing 15 μl (1.5 × 107) of formalin-fixed bacteria were mixed
with double-strength sample buffer and heated to 95°C for 30 min before
loading. After separation of the bands, the gels were stained with copper [16]
for visualization of the proteins, destained, and transferred to a polyvinylidine
difluoride (PDVF) membranes for Western blotting. Membranes were
blocked, incubated overnight at 37ºC with antisera (1:1000 working dilution)
and then with horseradish peroxidase (HRP)-conjugated goat anti-rabbit
immunoglobulins or HRP-conjugated goat anti-mouse immunoglobulins.
The immune complexes were visualized with 4-chloro-1-naphthol. Analysis
of the antigens and calculation of the molecular weight of the protein of inter-
est were done using Quantity One sofware (Bio-Rad Laboratories, Spain).
Diagonal electrophoresis. SDS-PAGE consisting of 7.5–15% gradi-
ent gels and standard electrophoretic settings was used for both the first and
second dimension in diagonal electrophoresis as described previously [30]. 
Antisera. Mouse sera against OMVs were obtained as described before
[31]. Rabbit sera against P47 and OMVs from strain Nm30 were obtained by
modification of a protocol described by Vaitukaitis [36]. Briefly, 2-kg New-
Zealand rabbits were immunized by either multiple intradermal injection
with 500 μg of OMVs or 13 mg of purified P47, in 500 μl of Freund’s com-
plete adjuvant. On day 54, the rabbits were injected intramuscularly with the
same amounts of immunogen in 100 μl of PBS, and two more doses were
administered at 8-day intervals. Rabbits were bled by cardiac puncture 12
days after the last injection and the sera obtained were heat-inactivated and
stored at –20ºC in 250-μl aliquots. Non-immune sera were obtained from
animals injected with Freund’s adjuvant (without any antigen) following the
same immunization schedule.
Dot-blotting assays. For dot-blot enzyme assays [8], 1.5 × 106 forma-
lin-fiexed cells (1.5 μl bacterial suspension) were spotted onto nitrocellulose
membranes (0.45 μm , Bio-Rad, Richmond, CA, USA) and allowed to dry
at room temperature. The membranes were then incubated with blocking
solution (TBS with 5% Blotto, Bio-Rad, USA) at room temperature, washed
three times with TBS-Tween (0.05% Tween-20 in TBS), and then probed
with the same sera used for Western blotting. Accessibility was tested in
some of the membranes by treating them with chloroform vapors for 20 min
and then probing them with antisera. Negative controls consisted of 1.5 μl of
a solution containing 2 mg bovine serum albumin (BSA)/ml in TBS-Tween.
Bactericidal activity. Bactericidal assays were carried out as previous-
ly described, using N. meningitidis strains Nm30 and B16B6 for the tests,
and human serum as source of complement (adsorbed with each target strain
and tested with non-immune mouse serum to confirm the absence of non-
specific killing) [29]. Negative controls without immune serum, comple-
ment, or both were included, and at least two assays, with three replicates
each, were carried out on different days. Bactericidal activity is expressed as
the mean percentage reduction in the number of colony-forming units
(CFUs) with respect to those obtained in experiments with non-immune
mouse serum. CFU reductions of more than 50% were considered indicative
of significant bactericidal activity [12].
Results
Cultivation of N. meningitidis strain Nm30 under conditions
of iron restriction strongly induced the production of P47
protein. After the OMPs were solubilized with Triton X–114,
the protein partitioned into the detergent phase (Fig. 1).
When solubilized in electrophoresis sample buffer, the band-
CONSERVED ANTIGEN IN NEISSERIA
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ing pattern of P47 overlapped with that of a minor antigenic
protein of similar molecular mass that was not inducible by
iron restriction (not shown). Purification by elution from
SDS-polyacrylamide gels of the detergent-phase extracts
yielded highly purified, homogeneous P47, as shown by
SDS-PAGE, Western blotting with homologous anti-OMV
mouse sera, and MALDI-TOF peptide-map fingerprinting
analysis (Table 2). Accordingly, this protein was identified
with the products of genes NMA0281 (N. meningitidis strain
Z2491, serogroup A), NMB0035 (N. meningitidis strain
MC58, serogroup B), NMC65c08 (N. meningitidis strain
FAM18, serogroup C), and NG02050 (N. gonorrhoeae strain
FA1090).
To determine whether P47 formed complexes with other
OMPs, diagonal electrophoresis of these proteins from strain
Nm30 was carried out under non-denaturing conditions in the
first-dimension run, and either non-denaturing (Fig. 2A) or
denaturing (Fig. 2B) conditions in the second-dimension run.
Some proteins formed complexes that could be resolved by
heat treatment (spots under the diagonal) or whose mobility
was heat-dependent (spots over the diagonal). The correspon-
ding Western blots, probed using anti-P47 serum (Figs.
2C,D), showed that the 47-kDa protein did not form com-
plexes with other OMPs, since it appeared only in the diago-
nal regardless of the analytical condition.
The expression of P47 in N. meningitidis and the com-
mensal neisserial strains tested as well as the cross-reactivity
of the anti-P47 antibodies were analyzed in Western blots
using a rabbit serum specific for the protein (Fig. 3). P47 was
detected in all 33 strains analyzed, although reactivity with
anti-P47 rabbit serum was slighty lower in N. lactamica
strains and much lower in the other commensal strains of
Neisseria (Fig. 3A). The antiserum did not cross-react with
any other protein in the Western blots. Moreover, the reactiv-
ity of the serum with formalin-fixed whole cells in dot-blots
was highly variable and did not correlate with in the results
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Table 2. MASCOT search results obtained by MALDI-TOF analysis of purified P47 of Neisseria meningitidis*
Observed Mr (expected) Mr (calculated) Delta Start–end Miss Peptide
1034.60
1058.68 
1150.64 
1157.65
1203.59 
1413.87
1541.96 
1544.84 
1735.93
1797.00 
1883.88 
1928.98
1944.99
2027.05
2052.01
2670.25
1033.59
1057.67
1149.63
1156.64
1202.59 
1412.87
1540.95
1543.84
1734.92 
1795.99
1882.87 
1927.97
1943.98 
2026.04
2051.01
2669.24
1033.54
1057.62
1149.64
1156.61
1202.55
1412.84
1540.93
1543.81
1734.92 
1795.98 
1882.83 
1927.97 
1943.96
2026.06 
2051.01
2669.18
0.05
0.05
–0.00
0.03
0.04
0.03
0.02 
0.03
0.00
0.01
0.04
0.01
0.02 
–0.02
0.00
0.06
145–153
77–84
124–134
262–272
349–358
314–325
313–325
273–288
232–246
366–382
296–312
85–102
85–102
196–213
126–144
289–312
0
1
1
0
1
0
1
0
1
0
0
1
1
0
1
1
LSQPLADYK
KLEWEILK
GKLVVTDSGFK
EIDALAFPPGK
TKDGFETYDK
IVDLFRPLIEAK
IVDLFRPLIEAK
VVGGASELIEEVAGSK
IEYALWVEKDVSGVK
ALQASINALAEDLAQLR
YSHTDLSDFQANVDGSK
GVMVVDERENIAPGLSDKYSHTDLSDFQANVDGSK
GVMVVDERENIAPGLSDKM
IEPIAELFSELDPVIDAR
LVVTDSGFKDTANEADLEK
ISGEEDRYSHTDLSDFQANVDGSK
*Mass: 42396; score: 203; expect: 9.6e-015; peptides matched: 16
Identification: conserved hypothetical protein NMB0035 (Neisseria meningitidis MC58)
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Fig. 1. Western blots of outer-membrane proteins (OMPs) from strain
Neisseria meningitidis Nm30 cultured in normal (+Fe) or iron-restricted
(–Fe) media and solubilized with Triton X-114. The proteins were separated
by SDS-PAGE and probed with homologous anti-OMV mouse serum.
Lanes: A and B, aqueous phases; C and D, detergent phases; E, purified P47
protein. MW, molecular mass markers (kDa).
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of the Western blots (Fig. 3B). This suggested that P47 is
masked in whole cells by capsular material. To test this pos-
sibility, cells were permeabilized with ethanol prior to fixa-
tion with formaldehyde and then analyzed by dot-blotting.
The permeabilized cells did not show an increase in the
accessibility of P47 to antibodies, and, for some strains, reac-
tivity was even lower in the ethanol-treated cells. Delipidation
with chloroform also failed to increase the surface exposure
of P47 (not shown).
Bactericidal activity assays showed that anti-P47 serum
had significant bactericidal activity against the homologous
bacterial strain (Nm30), with 77% killing compared to the
control. However, the efficacy of the antiserum against the
four heterologous strains tested was variable, ranging from a
CONSERVED ANTIGEN IN NEISSERIA
Fig. 3. (A) Western blots of OMPs
from Neisseria meningitidis and
commensal neisserial strains sepa-
rated by SDS-PAGE and probed
with a rabbit antiserum raised
against purified P47. (B) Reactivity
of the antiserum with formalin-
fixed cells in dot-blotting assays. In
t. 
M
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.
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Fig. 2. Two-dimensional diagonal electrophoresis of
OMPs from Neisseria meningitidis Nm30. The first
dimension was run with samples treated at ambient tempe-
rature in all cases, and the second dimension after treat-
ment at ambient temperature (A, C) or 95°C (B, D). Gels
were either stained with Coomassie blue (A, B) or the pro-
teins were transferred to PVDF membranes and further
analyzed by Western blotting with anti-P47 sera (C, D).
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minimum of 2% to a maximum of 42%. Bactericidal activity
against other strains was not measured as it was not possible
to remove the natural killing activity from the human serum
used as the complement source.
Discussion
´The development of vaccines effective against serogroup B
meningococci is a major challenge for researchers in this
field. Antigens suitable for effective vaccines should be high-
ly conserved, easily accessible at the bacterial surface, and
able to elicit long-lasting bactericidal responses. Currently,
the most promising approaches are based on bacterial OMPs,
which are being investigated by several strategies, including
reverse vaccinology [1], heterologous commensal strains
[10], and multiple PorA expression mutants [18]. In previous
studies, we identified a meningococcal, outer-surface iron-
repressible protein that showed high antigenic conservation
among meningococcal strains [35]. 
Attempts to purify P47 by excision from SDS-PAGE
gels, after separation of OMPs isolated from iron-restricted
meningococcal cultures and solubilized with SDS (elec-
trophoresis sample buffer), resulted in the co-purification of
P47 with another protein of similar molecular mass. The lat-
ter protein was detected by MALDI-TOF analysis and iden-
tified as the translation elongation factor Tu (N. meningitidis
MC58; GenBank accession number NP_273197). The use of
Triton X-114 for the solubilization of OMPs resulted in the
partition of P47 into the detergent phase and allowed its
purification to homogeneity, as verified by MALDI-TOF
analysis. P47 homologues in annotated meningococcal
genome databases [http://www.tigr.org] are described as a
“predicted periplasmic lipoprotein involved in iron trans-
port” (NMB0035), or as a “putative lipoprotein containing
N-terminal signal sequence and appropriately positioned
PS00013 prokaryotic membrane lipoprotein lipid attachment
site” (NMA0281). The partition of P47 largely in the deter-
gent phase strongly suggests its membrane localization [5].
Strain N. meningitidis Nm30 was chosen for purification
of P47 due to its high expression of the protein after cultiva-
tion under iron-restricted conditions. The purification proce-
dure was also tested in other strains, and a highly purified
product was obtained from each of them. The rabbit serum
resulting from immunization with purified P47 was highly
specific in Western blotting assays, did not react with any
other OMP, and cross-reacted completely with all Neisseria
strains tested. The faint bands visible in some strains were
probably due to non-specific reactions because they did not
appear in the overstained control of the homogenous product
obtained during purification. The reactivity of the antiserum
was slightly lower with N. lactamica strains and much lower
with the other commensal species, which could have been
due to lower P47 expression levels or to differences in the
accessibility of P47 at the surfaces of different bacterial
species.
Formalin-fixed bacterial cells were used to avoid possible
alterations in the bacterial cell surfaces (and in the accessibil-
ity of surface components) arising from the drying step in the
dot-blotting procedure. Results obtained with anti-P47 sera
and formalin-fixed cells were identical to those using live
intact cells (data not shown) and demonstrated the accessibil-
ity of P47 at the bacterial surface, although it revealed differ-
ences both among N. meningitidis strains and between N.
meningitidis and the commensal strains of Neisseria. These
differences suggested substantial variability in the expres-
sion, surface accessibility, or epitope arrangement of P47 in
the different strains. Western blotting showed that reactivity
with the anti-P47 serum was through linear epitopes, and dif-
ferences between strains were not very apparent (except for
the commensal Neisseria). These results suggested that the
reason for the inter-strain variability observed in the dot-blot-
ting experiments was the accessibility and/or epitope
arrangement of P47.
Antigen masking in N. meningitidis by surface structures,
such as the capsule and lipopolysaccharides (LPSs), has been
reported [24,25]. Ethanol treatment removes removes neisse-
rial capsular polysaccharide and LPS, exposes surface anti-
gens, and thus facilitates their accessibility to antibodies [19].
In N. meningitidis, the capsular structure and/or the amount
and length of lipooligosaccharides (LOSs) can significantly
vary between strains. Most commensal Neisseria lack a cap-
sule and have specific LOSs due to the absence of lgt genes
(LOS glycosyltransferase) in most species [14,28–32].
The possibility that binding of anti-P47 antibodies to
ethanol-treated and untreated cells was sterically hindered
was investigates in a capsulated strain (NMB) and its non-
capsulated mutant (M7). Ethanol has been reported to dam-
age the outer structures of bacteria, partially eliminating the
capsule and LOS outer residues, thereby exposing surface
proteins to antibodies [14]. Our results showed no significant
effects of ethanol or chloroform on P47 exposure to antibod-
ies, whereas treatment with both reagents abolished reactivi-
ty in the two commensal Neisseria strains tested. Such effects
could have been due to the effective removal of reactive anti-
genic residues, which, in turn, was facilitated by the lower
expression of P47 and/or by differences in the surface com-
position (lack of capsule and different LOS) of the commen-
sals. Other authors have noted no effect of the capsular mate-
rial on surface antigen accessibility [4], which, together with
279INT. MICROBIOL. Vol. 9, 2006
our results, suggests that LOS are responsible for the differ-
ences in the antibody accessibility of P47.
Bactericidal activity was measured in only a limited num-
ber of strains due to the impossibility of removing the natu-
ral bactericidal activity of human serum (used as the comple-
ment source) against other strains. Sera from agammaglobu-
linemic individuals, which would have been the best choice
for these kinds of experiments, were not available.
Nonetheless, a certain degree of correlation between bacteri-
cidal activity and the reaction intensity in dot-blot experi-
ments was observed. An exception was strain Nm9, which
reacted with the antiserum to an extent similar to the reaction
of B16B6, even though it showed a much lower bactericidal
activity. It has to be taken into account that the intensity in
dot-blotting experiments is due to the binding of any anti-
body subclass, whereas bactericidal activity is related only to
the binding of bactericidal subclasses; thus, the two measure-
ments do not necessarily correlate.
A recent study by Giuliani et al. [9] demonstrated a high-
ly efficient (>78%) vaccine formulation containing five
genome-derived antigens, which confirms that protein-based
vaccines are good alternatives for serogroup-independent
immunization against N. meningitidis. The present work
showed the antigenic cross-reactivity of P47 in a great num-
ber of N. meningitidis strains and in some commensal
Neisseria, particularly N. lactamica, as well as its surface
exposition and the bactericidal activity of anti-P47 antibod-
ies. Work in progress is focused on the analysis of sequence
variability in the p47 gene in all strains, determination of sur-
face exposure of the protein by flow cytometry, and analysis
of the bactericidal activity of anti-P47 sera in a larger num-
ber of strains. The results should help to determine the anti-
genic variability of P47 and the applicability of this protein
in future vaccine designs.
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ARENAS ET AL.
El locus NMB0035 codifica un antígeno de
superficie conservado de 47 kDa en Neisseria
Resumen. El tratamiento con Triton X-114, seguido de la separación por
SDS-PAGE permitió la purificación de una proteína antigénica de 47 kDa (P47)
de la membrana externa de Neisseria de forma homogénea, lo que permitió la
preparación de sueros policlonales anti-P47. La P47 se identificó como la lipo-
proteína (hipotética) NMB0035 mediante el análisis de la huella molecular rea-
lizado por MALDI-TOF. Los resultados obtenidos por SDS-PAGE diagonal
bidimensional sugieren que, a diferencia de otros resultados previos, la P47 no
parece estar fuertemente asociada a otras proteínas en complejos de membrana.
Análisis de inmunoelectrotransferencia (Western blot) empleando el suero poli-
clonal monoespecífico demostró que los epítopos lineales de la P47 se expresa-
ron de forma similar en las 27 cepas de Neisseria meningitidis ensayadas y,
aunque con menor intensidad, también lo hicieron en algunas Neisseria comen-
sales, especialmente en N. lactamica. Sin embargo, resultados obtenidos por
transferencia de mancha con el mismo suero demostraron que entre las cepas
meningocócicas existe variabilidad en la capacidad de unión, lo que sugiere que
o bien hay diferencias en la accesibilidad en superficie o bien una ocultación
estérica producida por otras estructuras de superficie. Los anticuerpos específi-
cos anti-P47 tenían efecto bactericida contra la cepa homóloga pero mostraron
una actividad variable contra cepas heterólogas, lo cual concuerda con los
resultados de la transferencia de mancha, y hace pensar que es necesario estu-
diar esta proteína más profundamente para evaluar su potencial como candida-
ta para nuevos diseños de vacunas. [Int Microbiol 2006; 9(4):273-280]
Palabras clave: Neisseria meningitidis · Neisseria lactamica · antígenos
de superficie · antígenos conservados · proteínas de la membrana externa
O locus NMB0035 codifica um antígeno de
superfície conservado de 47 kDa em Neisseria
Resumo. O tratamento com Triton X-114, seguido da separação por
SDS-PAGE permitiu a purificação de uma proteína antigênica de 47 kDa
(P47) de Neisseria de forma homogênea, o que possibilitou a obtenção de
soros policlonais anti-P47. A P47 foi identificada por MALDI-TOF como
a lipoproteína (hipotética) NMB0035. Os resultados obtidos por SDS-
PAGE diagonal em duas dimensões sugerem que, ao contrario de resulta-
dos prévios, a P47 não parece estar estreitamente associada a outras pro-
teínas em complexos de membrana. Análise de transferência de Western
empregando o soro policlonal monoespecífico mostram que os epitopos
lineares da P47 se expressaram de forma similar nas 27 cepas de Neisseria
meningitidis ensaiadas e, mesmo que com menor intensidade, também o
fizeram em algumas Neisseria comensais, especialmente em N. lactamica.
No entanto, resultados obtidos por dot blotting com o mesmo soro demons-
traram que entre as cepas meningocócicas existe variabilidade na capaci-
dade de união, o que sugere que há diferenças na acessibilidade em super-
fície ou uma ocultação estérica produzida por outras estruturas de superfí-
cie. Os anticorpos específicos anti-P47 foram bactericidas contra a cepa
homóloga mas mostraram uma atividade variável contra cepas heterólogas,
o que coincide com os resultados de dot blotting, indicando que é necessá-
rio realizar estudos desta proteína em maior profundidade para avaliar seu
potencial como candidato a novos desenhos de vacinas. [Int Microbiol
2006; 9(4):273-280]
Palavras chave: Neisseria meningitidis · Neisseria lactamica · antigenos
de superficie · antigenos conservados · proteínas da membrana externa
